A detailed history of Susquehanna International Group, LLP transactions in Care Dx, Inc. stock. As of the latest transaction made, Susquehanna International Group, LLP holds 11,803 shares of CDNA stock, worth $252,820. This represents 0.0% of its overall portfolio holdings.

Number of Shares
11,803
Previous 160,350 92.64%
Holding current value
$252,820
Previous $2.49 Million 85.22%
% of portfolio
0.0%
Previous 0.0%

Shares

24 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$14.41 - $33.99 $2.14 Million - $5.05 Million
-148,547 Reduced 92.64%
11,803 $368,000
Q2 2024

Aug 15, 2024

BUY
$7.56 - $16.15 $945,612 - $2.02 Million
125,081 Added 354.65%
160,350 $2.49 Million
Q1 2024

May 07, 2024

SELL
$7.96 - $12.37 $634,841 - $986,556
-79,754 Reduced 69.34%
35,269 $373,000
Q4 2023

Feb 14, 2024

BUY
$4.9 - $12.86 $403,338 - $1.06 Million
82,314 Added 251.66%
115,023 $1.38 Million
Q3 2023

Nov 14, 2023

SELL
$7.0 - $11.26 $295,323 - $475,048
-42,189 Reduced 56.33%
32,709 $228,000
Q2 2023

Aug 11, 2023

SELL
$7.61 - $9.46 $1.07 Million - $1.33 Million
-140,104 Reduced 65.16%
74,898 $636,000
Q1 2023

May 16, 2023

BUY
$8.83 - $17.61 $938,999 - $1.87 Million
106,342 Added 97.87%
215,002 $1.97 Million
Q4 2022

Feb 14, 2023

SELL
$10.88 - $20.05 $46,000 - $84,771
-4,228 Reduced 3.75%
108,660 $1.24 Million
Q3 2022

Nov 14, 2022

BUY
$16.06 - $26.39 $1.28 Million - $2.1 Million
79,468 Added 237.79%
112,888 $1.92 Million
Q2 2022

Aug 15, 2022

SELL
$20.49 - $39.72 $381,134 - $738,831
-18,601 Reduced 35.76%
33,420 $718,000
Q1 2022

May 16, 2022

SELL
$28.19 - $46.6 $1.16 Million - $1.92 Million
-41,223 Reduced 44.21%
52,021 $1.92 Million
Q4 2021

Feb 14, 2022

BUY
$41.2 - $73.6 $1.68 Million - $2.99 Million
40,670 Added 77.36%
93,244 $4.24 Million
Q3 2021

Nov 15, 2021

BUY
$59.15 - $91.99 $1.82 Million - $2.83 Million
30,735 Added 140.73%
52,574 $3.33 Million
Q2 2021

Aug 11, 2021

BUY
$63.02 - $95.11 $433,955 - $654,927
6,886 Added 46.05%
21,839 $2 Million
Q1 2021

May 17, 2021

SELL
$57.62 - $95.6 $2.73 Million - $4.54 Million
-47,444 Reduced 76.04%
14,953 $1.02 Million
Q4 2020

Feb 16, 2021

BUY
$41.43 - $77.09 $1.98 Million - $3.68 Million
47,777 Added 326.79%
62,397 $4.52 Million
Q3 2020

Nov 16, 2020

BUY
$30.88 - $37.94 $187,441 - $230,295
6,070 Added 70.99%
14,620 $555,000
Q2 2020

Aug 14, 2020

SELL
$18.95 - $35.43 $539,771 - $1.01 Million
-28,484 Reduced 76.91%
8,550 $303,000
Q1 2020

May 15, 2020

SELL
$13.94 - $28.25 $268,428 - $543,982
-19,256 Reduced 34.21%
37,034 $808,000
Q4 2019

Feb 14, 2020

SELL
$19.24 - $28.41 $841,903 - $1.24 Million
-43,758 Reduced 43.74%
56,290 $1.21 Million
Q3 2019

Nov 14, 2019

BUY
$20.03 - $40.08 $1.12 Million - $2.24 Million
55,777 Added 125.99%
100,048 $2.26 Million
Q2 2019

Aug 16, 2019

BUY
$25.78 - $39.77 $1.14 Million - $1.76 Million
44,271 New
44,271 $1.59 Million
Q2 2018

Aug 14, 2018

SELL
$7.93 - $15.79 $748,988 - $1.49 Million
-94,450 Closed
0 $0
Q1 2018

May 15, 2018

BUY
$5.18 - $7.97 $489,251 - $752,766
94,450 New
94,450 $753,000

Others Institutions Holding CDNA

About CareDx, Inc.


  • Ticker CDNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 53,458,100
  • Market Cap $1.15B
  • Description
  • CareDx, Inc. discovers, develops, and commercializes diagnostic solutions for transplant patients and caregivers worldwide. It provides AlloSure Kidney, a donor-derived cell-free DNA (dd-cfDNA) solution for kidney transplant patients; AlloMap Heart, a gene expression solution for heart transplant patients; AlloSure Heart, a dd-cfDNA solution for...
More about CDNA
Track This Portfolio

Track Susquehanna International Group, LLP Portfolio

Follow Susquehanna International Group, LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.